Literature DB >> 24143888

Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes.

Emer Fitzpatrick1, Yue Wu, Paramjeet Dhadda, Robin D Hughes, Ragai R Mitry, Hong Qin, Sharon C Lehec, Nigel D Heaton, Anil Dhawan.   

Abstract

Hepatocyte transplantation is becoming an accepted therapy for acute liver failure, either as a bridge to liver regeneration or to organ transplantation. Hepatocytes provide liver function in place of the failing organ. The maintenance of sufficient viability and function of the transplanted hepatocytes is a concern. There is a lot of recent interest in mesenchymal stem cells (MSCs) for the provision of structural and trophic support to hepatocytes, but few studies currently use primary human hepatocytes. The aim of this study was to investigate if coculture of human MSCs with cryopreserved human hepatocytes may improve their function and viability, thus with potential for cellular therapy of liver disease. MSCs were isolated from human umbilical cord or adipose tissue. Hepatocytes were isolated from donor organs unsuitable for transplantation. MSCs and hepatocytes were cocultured in both direct and indirect contact. Conditioned medium (CM) from cocultured MSCs and hepatocytes was also used on hepatocytes. Viability and liver-specific function were compared between test and controls. Human hepatocytes that were cocultured directly with MSCs demonstrated improved production of albumin from day 5 to day 25 of culture. This effect was most prominent at day 15. Likewise, urea production was improved in coculture from day 5 to 25. Indirect coculture demonstrated improved albumin production by day 4 (1,107 ng/ml) versus hepatocyte monoculture (940 ng/ml). Hepatocytes in CM demonstrated a nonsignificant improvement in function. The viability of cocultured hepatocytes was superior to that of monocultured cells with up to a 16% improvement. Thus, coculture of human hepatocytes with MSCs demonstrates both improved function and viability. The effect is seen mainly with direct coculture but can also be seen in indirect culture and with CM. Such coculture conditions may convey major advantages in hepatocyte survival and function for cell transplantation.

Entities:  

Mesh:

Year:  2013        PMID: 24143888     DOI: 10.3727/096368913X674080

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  18 in total

Review 1.  Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.

Authors:  Clara T Nicolas; Raymond D Hickey; Harvey S Chen; Shennen A Mao; Manuela Lopera Higuita; Yujia Wang; Scott L Nyberg
Journal:  Stem Cells       Date:  2016-10-02       Impact factor: 6.277

Review 2.  Cell-based liver therapies: past, present and future.

Authors:  Valeria Iansante; Anil Chandrashekran; Anil Dhawan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 3.  Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.

Authors:  Jie Wang; Meiyan Sun; Wei Liu; Yan Li; Miao Li
Journal:  Tissue Eng Regen Med       Date:  2019-02-21       Impact factor: 4.169

4.  Human adipose-derived mesenchymal stem cells promote recovery of injured HepG2 cell line and show sign of early hepatogenic differentiation.

Authors:  Ling Ling Liau; Suzana Makpol; Abdul Ghani Nur Azurah; Kien Hui Chua
Journal:  Cytotechnology       Date:  2018-03-16       Impact factor: 2.058

5.  Engineered Liver Tissue Culture in an In Vitro Tubular Perfusion System.

Authors:  Guang Yang; Bhushan Mahadik; Trevor Mollot; Julia Pinsky; Athenia Jones; Alexis Robinson; Daniel Najafali; Daniel Rivkin; Jenny Katsnelson; Charlotte Piard; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-11-24       Impact factor: 3.845

6.  Efficient One-Step Production of Microencapsulated Hepatocyte Spheroids with Enhanced Functions.

Authors:  Hon Fai Chan; Ying Zhang; Kam W Leong
Journal:  Small       Date:  2016-04-01       Impact factor: 13.281

7.  Amniotic mesenchymal stem cells derived hepatocyte-like cells attenuated liver fibrosis more efficiently by mixed-cell transplantation.

Authors:  Hui Wang; Yuan Tian; Xin Li; Meijia Yang; Ying Yan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-02-25

Review 8.  Human hepatocyte transplantation for liver disease: current status and future perspectives.

Authors:  V Iansante; R R Mitry; C Filippi; E Fitzpatrick; A Dhawan
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

Review 9.  Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.

Authors:  Xiang-Rui Ma; Ya-Ling Tang; Ming Xuan; Zheng Chang; Xiao-Yi Wang; Xin-Hua Liang
Journal:  Gastroenterol Res Pract       Date:  2015-03-15       Impact factor: 2.260

10.  Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts.

Authors:  Kamil S Sitarz; Hannah R Elliott; Betül S Karaman; Caroline Relton; Patrick F Chinnery; Rita Horvath
Journal:  Mol Genet Metab       Date:  2014-03-28       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.